On November 7, 2018 Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, reported that it will participate in the following investor conferences in November (Press release, Audentes Therapeutics, NOV 7, 2018, View Source [SID1234530902]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 27th Annual Healthcare Conference Natalie Holles, President and Chief Operating OfficerFormat: 1×1 Investor MeetingsWednesday, November 14, 2018Scottsdale, Arizona
Evercore ISI HealthConX Conference Matthew R. Patterson, Chairman and Chief Executive OfficerFormat: Fireside ChatTuesday, November 27, 2018, 10:35am ESTBoston, Massachusetts
Piper Jaffray 30th Annual Healthcare Conference Matthew R. Patterson, Chairman and Chief Executive OfficerFormat: Fireside ChatWednesday, November 28, 2018, 11:30am ESTNew York, New York
Barclays Gene Editing & Gene Therapy SummitMatthew R. Patterson, Chairman and Chief Executive OfficerFormat: Corporate PresentationThursday, November 29, 2018, 10:15am ESTNew York, New York
To access live webcasts of the fireside chats and presentation please visit the Events & Presentations page within the Investors + Media section of the Audentes website. Following each conference, a replay of the live webcast will be available on the Audentes website for approximately 30 days.